What's priced into Supermicro (SMCI) stock?

The market appears to price SMCI as a cheap option compared to its peers, reflecting a justified valuation. There is a low expectations gap, indicating that investors are not overly optimistic about future performance.

What does the Supermicro (SMCI) outlook hinge on?

The long-term thesis hinges on management's ability to maintain guidance and deliver on revenue targets. Additionally, external factors like Federal Reserve rate changes and performance of sector peers will play a crucial role.

Supermicro (SMCI) Outlook: What's Priced In

What could strengthen or challenge Supermicro’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

-0.0%

+10% or more+5%0%−5%−10% or less

5.35 → 5.35 EPS · FY ending Jun 30, 2028 · 10 analysts

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

Change in the same fiscal period’s mean EPS estimate from Sep 15, 2026 to Oct 15, 2026: (new ÷ prior − 1). Contributor count changed from 9 to 10; this is not the number of analysts revising. Source: FMP consensus snapshots. The ±10% axis is a display range.

Twelve-year operating bridge · estimated, unvalidated forecasts
Operating measure	Path	FY2027	FY2028	FY2029
RevenueUSD B	Projected	68.50	79.69	95.63
Revenue growth	Projected	75.4%	16.3%	20.0%
Operating marginExecution focus	Projected	9.5%	10.5%	10.5%
Common earningsUSD B	Projected	4.88	6.42	7.76
EPSUSD/share	Projected	7.44	9.77	11.82
Net reinvestmentUSD B	Projected	7.17	7.49	8.93
Gross cash capexUSD B	Projected	0.39	0.40	0.40
Depreciation / amort.USD B	Projected	0.07	0.08	0.08
Working capital addedUSD B	Projected	6.85	7.17	8.61
Common bookUSD B	Projected	18.90	26.73	36.13
Operating capitalUSD B	Projected	23.11	30.60	39.53
ROIC	Projected	32.6%	28.9%	26.2%
Common excess earningsUSD B	Projected	3.80	4.42	4.94
SharesB	Projected	0.66	0.66	0.66
Share change	Projected	0.0%	0.0%	0.0%
Net common cashUSD B	Projected	-3.76	-1.41	-1.64
Common-cash requirementUSD B	Projected	3.76	1.41	1.64
Forecast stage	explicit	explicit	explicit

Operating measure

Path

FY2027

FY2028

FY2029

RevenueUSD B

Projected

68.50

79.69

95.63

Revenue growth

Projected

75.4%

16.3%

20.0%

Operating marginExecution focus

Projected

9.5%

10.5%

Common earningsUSD B

Projected

4.88

6.42

7.76

EPSUSD/share

Projected

7.44

9.77

11.82

Net reinvestmentUSD B

Projected

7.17

7.49

8.93

Gross cash capexUSD B

Projected

0.39

0.40

Depreciation / amort.USD B

Projected

0.07

0.08

Working capital addedUSD B

Projected

6.85

7.17

8.61

Common bookUSD B

Projected

18.90

26.73

36.13

Operating capitalUSD B

Projected

23.11

30.60

39.53

ROIC

Projected

32.6%

28.9%

26.2%

Common excess earningsUSD B

Projected

3.80

4.42

4.94

SharesB

Projected

0.66

Share change

Projected

0.0%

Net common cashUSD B

Projected

-3.76

-1.41

-1.64

Common-cash requirementUSD B

Projected

3.76

1.41

1.64

Forecast stage

explicit

Compare the operating change with the company work identified in the published report. A named initiative is not proof that the price is achievable, and its value is not added on top of Living FV.

Calculate a target path to quantify the gap. Published projections and initiative links are shown now; a required path has not been calculated.

2026-06-30 to 2027-06-30 · consolidated model path · estimated, unvalidated forecasts. Accounting comparability with reported results is not established.

Revenue and growth

Revenue: Projected: $68,500,000,000.00
Scenario: Not calculated
Revenue growth: Projected: 75.4%
Scenario: Not calculated

Company initiatives in this report

12 source-declared links to this operating channel

international sales efforts
Included in consolidated path · unknown
Condition, timing and source
None
Model setting: International expansion and facility investments in Taiwan/Malaysia support revenue growth and capex; already embedded in FY2027 revenue and capex guidance.
Affected fields: revenue_growth, net_ppe_investment_ratio. This is a published model binding, not measured delivery or an incremental price contribution.
Source date: 2026-08-31 18:21:23+00:00. Initiative ID: Ib9b0c015f34c2dd8.
Source references: 876527 / 832ffbd2-14b1-5802-8f9d-2c230e16f6ff.
Initiative-specific comparable scope, accounting basis, units and full-year observation period are not declared in this binding. Delivery against the required path remains unverified.
develop more advanced, differentiated products
Included in consolidated path · unknown
Condition, timing and source
None
Model setting: Product differentiation and cost streamlining support margin and growth; already embedded in FY2027 revenue and margin guidance.
Affected fields: operating_margin, revenue_growth. This is a published model binding, not measured delivery or an incremental price contribution.
Source date: 2026-08-31 18:21:23+00:00. Initiative ID: Ie84807fcbc930a79.
Source references: 876527 / 6eb835c1-67b6-5c9a-b5df-233e989db11b.
Initiative-specific comparable scope, accounting basis, units and full-year observation period are not declared in this binding. Delivery against the required path remains unverified.
gigawatt-scale data center for SpaceX and xAI
Included in consolidated path · unknown
Condition, timing and source
Timing is 'within a year'; ownership and revenue split with SpaceX/xAI not disclosed.
Model setting: Co-building gigawatt-scale data center for SpaceX/xAI within a year; potential revenue and capex impact.
Affected fields: revenue_growth, net_ppe_investment_ratio. This is a published model binding, not measured delivery or an incremental price contribution.
Source date: 2026-08-12 13:46:29+00:00. Initiative ID: If799d6cc784aebd3.
Source references: 876811 / 5c85ef53-59ba-5980-9f6b-81bb8b4d2d17.
Initiative-specific comparable scope, accounting basis, units and full-year observation period are not declared in this binding. Delivery against the required path remains unverified.

Thesis drivers and incoming evidence (0)

No explicit thematic driver mapping is available.

Operating profitability

Operating margin: Projected: 9.5%
Scenario: Not calculated

Company initiatives in this report

12 source-declared links to this operating channel

strategic expansion
Included in consolidated path · unknown
Condition, timing and source
Cost savings and delivery improvements are qualitative; no specific dollar impact disclosed.
Model setting: Strategic expansion reduces manufacturing costs and delivery time; mitigates tariff impact.
Affected fields: operating_margin, net_ppe_investment_ratio. This is a published model binding, not measured delivery or an incremental price contribution.
Source date: 2026-08-31 18:21:23+00:00. Initiative ID: Id4a49a98aa3f2eab.
Source references: 876527 / 9599bfa8-9cb2-5f47-b41a-76ac593ace61.
Initiative-specific comparable scope, accounting basis, units and full-year observation period are not declared in this binding. Delivery against the required path remains unverified.
develop more advanced, differentiated products
Included in consolidated path · unknown
Condition, timing and source
None
Model setting: Product differentiation and cost streamlining support margin and growth; already embedded in FY2027 revenue and margin guidance.
Affected fields: operating_margin, revenue_growth. This is a published model binding, not measured delivery or an incremental price contribution.
Source date: 2026-08-31 18:21:23+00:00. Initiative ID: Ie84807fcbc930a79.
Source references: 876527 / 6eb835c1-67b6-5c9a-b5df-233e989db11b.
Initiative-specific comparable scope, accounting basis, units and full-year observation period are not declared in this binding. Delivery against the required path remains unverified.
richer enterprise customer mix
Included in consolidated path · progress reported
Condition, timing and source
Dependent on continued enterprise customer adoption and DCBBS architecture utilization.
Model setting: Improves profitability via richer enterprise mix and DCBBS adoption; contributes to gross margin expansion and revenue growth.
Affected fields: operating_margin, revenue_growth. This is a published model binding, not measured delivery or an incremental price contribution.
Source date: 2026-08-11 20:06:16+00:00. Initiative ID: I663c0cf27b548480.
Source references: 876615 / fe6e2a15-0757-579b-9ac3-79dbd02e35d8.
Initiative-specific comparable scope, accounting basis, units and full-year observation period are not declared in this binding. Delivery against the required path remains unverified.

Thesis drivers and incoming evidence (0)

No explicit thematic driver mapping is available.

Capital and cash timing

Net reinvestment: Projected: $7,175,000,000.00
Scenario: Not calculated
Net PPE investment: Projected: $325,000,000.00
Scenario: Not calculated
Working capital added: Projected: $6,850,000,000.00
Scenario: Not calculated
Common-cash requirement: Projected: $3,762,353,284.40
Scenario: Not calculated

Investment and funding are different. A modeled cash requirement needs a funding source, cost and ownership effect; cash-reserve policies are not interchangeable with financing.

Company initiatives in this report

12 source-declared links to this operating channel

international sales efforts
Included in consolidated path · unknown
Condition, timing and source
None
Model setting: International expansion and facility investments in Taiwan/Malaysia support revenue growth and capex; already embedded in FY2027 revenue and capex guidance.
Affected fields: revenue_growth, net_ppe_investment_ratio. This is a published model binding, not measured delivery or an incremental price contribution.
Source date: 2026-08-31 18:21:23+00:00. Initiative ID: Ib9b0c015f34c2dd8.
Source references: 876527 / 832ffbd2-14b1-5802-8f9d-2c230e16f6ff.
Initiative-specific comparable scope, accounting basis, units and full-year observation period are not declared in this binding. Delivery against the required path remains unverified.
strategic expansion
Included in consolidated path · unknown
Condition, timing and source
Cost savings and delivery improvements are qualitative; no specific dollar impact disclosed.
Model setting: Strategic expansion reduces manufacturing costs and delivery time; mitigates tariff impact.
Affected fields: operating_margin, net_ppe_investment_ratio. This is a published model binding, not measured delivery or an incremental price contribution.
Source date: 2026-08-31 18:21:23+00:00. Initiative ID: Id4a49a98aa3f2eab.
Source references: 876527 / 9599bfa8-9cb2-5f47-b41a-76ac593ace61.
Initiative-specific comparable scope, accounting basis, units and full-year observation period are not declared in this binding. Delivery against the required path remains unverified.
expand our production capacity
Included in consolidated path · progress reported
Condition, timing and source
Facilities costs include rental, utility, and depreciation; tied to capacity expansion efforts.
Model setting: Production capacity expansion driven by $20.7M increase in facilities costs; supports growing customer demand.
Affected fields: net_ppe_investment_ratio, working_capital_investment_ratio. This is a published model binding, not measured delivery or an incremental price contribution.
Source date: 2026-08-31 18:21:23+00:00. Initiative ID: If4a6b9084eaa6e8e.
Source references: 876527 / 9a4549e6-82e2-5bd7-8827-0a5f532e0182.
Initiative-specific comparable scope, accounting basis, units and full-year observation period are not declared in this binding. Delivery against the required path remains unverified.

Thesis drivers and incoming evidence (0)

No explicit thematic driver mapping is available.

4 published drivers remain unmapped to operating channels. Their original evidence remains in the thesis table.

Timing matters: changing a selected year does not shift an initiative's disclosed delivery date or establish that it can meet the requirement. Forecast outcomes are unknown; no numerical completion percentage is inferred.

25 unique initiative records shown from 239; 214 others, including unquantified or unsupported fields, remain in the full report. Selection prioritizes declared consolidated bindings, then source date, with up to 12 per channel. Inspect all source bindings.

Estimate revisions, ratings and analyst targets in Incoming Evidence describe expectations, not delivered outcomes. No initiative dollar attribution is claimed without an engine counterfactual.

Equity return	Living FV at report date
9.6%	$188.13
10.6%	$154.12
11.6%	$128.51

Equity return

Living FV at report date

9.6%

$188.13

10.6%

$154.12

11.6%

$128.51

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
Manage $7 billion capital raise without hurting growth	A supporting condition in Supermicro's published investment case. The stated target is Capital raise supports growth without margin erosion.	Improving	Capital raise causes revenue or margin decline below guidance	Op margin 13.4% vs 3.7% (Q2); Rev $11.1B vs $12.7B (Q2) Q4 results show strong margin expansion and revenue growth, reinforcing that the $7B raise supports AI demand without hurting profitability. Context reviewed through Oct 15, 2026Last status assessment Oct 15, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.

Key Factor

Why It Matters

Current Status

Break Condition

Latest Evidence

Manage $7 billion capital raise without hurting growth

A supporting condition in Supermicro's published investment case. The stated target is Capital raise supports growth without margin erosion.

Improving

Capital raise causes revenue or margin decline below guidance

Op margin 13.4% vs 3.7% (Q2); Rev $11.1B vs $12.7B (Q2)

Q4 results show strong margin expansion and revenue growth, reinforcing that the $7B raise supports AI demand without hurting profitability.

Context reviewed through Oct 15, 2026Last status assessment Oct 15, 2026Compare required operating outcomes

Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.

FY2028 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-07-24	Unavailable	$62,925,238,602	3 / 9
2026-07-25	Unavailable	$62,925,238,602	3 / 9
2026-07-26	Unavailable	$63,425,238,602	3 / 9
2026-07-27	Unavailable	$63,425,238,602	3 / 9
2026-07-28	Unavailable	$63,425,238,602	3 / 9
2026-07-29	Unavailable	$63,425,238,602	3 / 9
2026-07-30	Unavailable	$63,425,238,602	3 / 9
2026-07-31	Unavailable	$63,425,238,602	3 / 9
2026-08-01	Unavailable	$63,425,238,602	3 / 9
2026-08-02	Unavailable	$63,425,238,602	3 / 9
2026-08-03	Unavailable	$63,425,238,602	3 / 9
2026-08-04	Unavailable	$63,425,238,602	3 / 9
2026-08-05	Unavailable	$63,425,238,602	3 / 9
2026-08-06	Unavailable	$63,425,238,602	3 / 9
2026-08-08	Unavailable	$63,425,238,602	3 / 9
2026-08-09	Unavailable	$63,425,238,602	3 / 9
2026-08-10	Unavailable	$63,425,238,602	3 / 9
2026-08-12	$3.86	$64,866,883,440	9 / 9
2026-08-13	Unavailable	$63,425,238,602	3 / 9
2026-08-14	Unavailable	$63,425,238,602	3 / 9
2026-08-15	$3.68	$63,425,238,602	6 / 9
2026-08-16	$3.68	$63,425,238,602	6 / 9
2026-08-17	$3.68	$63,425,238,602	6 / 9
2026-08-18	$3.68	$63,425,238,602	6 / 9
2026-08-19	$3.68	$63,425,238,602	6 / 9
2026-08-20	$5.35	$79,014,681,318	6 / 9
2026-08-21	$5.35	$79,014,681,318	6 / 9
2026-08-22	$5.35	$79,014,681,318	7 / 9
2026-08-23	$5.35	$79,014,681,318	7 / 9
2026-08-24	$5.35	$79,014,681,318	7 / 9
2026-08-25	$5.35	$79,014,681,318	7 / 9
2026-08-26	$5.35	$79,014,681,318	7 / 9
2026-08-27	$5.35	$79,014,681,318	7 / 9
2026-08-28	$5.35	$79,014,681,318	7 / 9
2026-08-29	$5.35	$79,014,681,318	7 / 9
2026-08-30	$5.35	$79,014,681,318	7 / 9
2026-08-31	$5.35	$79,014,681,318	7 / 9
2026-09-01	$5.35	$79,014,681,318	7 / 9
2026-09-02	$5.35	$79,014,681,318	7 / 9
2026-09-03	$5.35	$79,014,681,318	7 / 9
2026-09-04	$5.35	$79,014,681,318	7 / 9
2026-09-05	$5.35	$79,014,681,318	7 / 9
2026-09-06	$5.35	$79,014,681,318	7 / 9
2026-09-07	$5.35	$79,014,681,318	9 / 11
2026-09-08	$5.35	$79,014,681,318	9 / 11
2026-09-09	$5.35	$79,014,681,347	9 / 11
2026-09-10	$5.35	$79,014,681,347	9 / 11
2026-09-11	$5.35	$79,014,681,347	9 / 11
2026-09-12	$5.35	$79,014,681,347	9 / 11
2026-09-13	$5.35	$79,014,681,347	9 / 11
2026-09-14	$5.35	$79,014,681,347	9 / 11
2026-09-15	$5.35	$79,014,681,347	9 / 11
2026-09-16	$5.35	$79,014,681,347	9 / 11
2026-09-17	$5.35	$79,014,681,347	9 / 11
2026-09-18	$5.35	$79,014,681,347	9 / 11
2026-09-19	$5.35	$79,014,681,347	9 / 11
2026-09-20	$5.35	$79,014,681,347	9 / 11
2026-09-21	$5.35	$79,014,681,347	9 / 11
2026-09-22	$5.35	$79,014,681,347	9 / 11
2026-09-23	$5.35	$79,014,681,347	9 / 11
2026-09-24	$5.35	$79,014,681,347	9 / 11
2026-09-25	$5.35	$79,014,681,347	9 / 11
2026-09-26	$5.35	$79,014,681,347	9 / 11
2026-09-27	$5.35	$79,014,681,347	9 / 11
2026-09-28	$5.35	$79,014,681,347	9 / 11
2026-09-29	$5.35	$79,014,681,347	10 / 12
2026-09-30	$5.35	$79,014,681,347	10 / 12
2026-10-01	$5.35	$79,014,681,347	10 / 12
2026-10-02	$5.35	$79,014,681,347	10 / 12
2026-10-03	$5.35	$79,014,681,347	10 / 12
2026-10-04	$5.35	$79,014,681,347	10 / 12
2026-10-05	$5.35	$79,014,681,347	10 / 12
2026-10-06	$5.35	$79,014,681,347	10 / 12
2026-10-07	$5.35	$79,014,681,347	10 / 12
2026-10-08	$5.35	$79,014,681,347	10 / 12
2026-10-09	$5.35	$79,014,681,347	10 / 12
2026-10-10	$5.35	$79,014,681,347	10 / 12
2026-10-11	$5.35	$79,014,681,347	10 / 12
2026-10-12	$5.35	$79,014,681,347	10 / 12
2026-10-13	$5.35	$79,014,681,347	10 / 12
2026-10-14	$5.35	$79,014,681,347	10 / 12
2026-10-15	$5.35	$79,014,681,347	10 / 12

FY2028 estimate observations · fmp

Snapshot

EPS

Revenue

EPS / revenue analysts

2026-07-24

Unavailable

$62,925,238,602

3 / 9

2026-07-25

Unavailable

$62,925,238,602

3 / 9

2026-07-26

Unavailable

$63,425,238,602

3 / 9

2026-07-27

Unavailable

$63,425,238,602

3 / 9

2026-07-28

Unavailable

$63,425,238,602

3 / 9

2026-07-29

Unavailable

$63,425,238,602

3 / 9

2026-07-30

Unavailable

$63,425,238,602

3 / 9

2026-07-31

Unavailable

$63,425,238,602

3 / 9

2026-08-01

Unavailable

$63,425,238,602

3 / 9

2026-08-02

Unavailable

$63,425,238,602

3 / 9

2026-08-03

Unavailable

$63,425,238,602

3 / 9

2026-08-04

Unavailable

$63,425,238,602

3 / 9

2026-08-05

Unavailable

$63,425,238,602

3 / 9

2026-08-06

Unavailable

$63,425,238,602

3 / 9

2026-08-08

Unavailable

$63,425,238,602

3 / 9

2026-08-09

Unavailable

$63,425,238,602

3 / 9

2026-08-10

Unavailable

$63,425,238,602

3 / 9

2026-08-12

$3.86

$64,866,883,440

9 / 9

2026-08-13

Unavailable

$63,425,238,602

3 / 9

2026-08-14

Unavailable

$63,425,238,602

3 / 9

2026-08-15

$3.68

$63,425,238,602

6 / 9

2026-08-16

$3.68

$63,425,238,602

6 / 9

2026-08-17

$3.68

$63,425,238,602

6 / 9

2026-08-18

$3.68

$63,425,238,602

6 / 9

2026-08-19

$3.68

$63,425,238,602

6 / 9

2026-08-20

$5.35

$79,014,681,318

6 / 9

2026-08-21

$5.35

$79,014,681,318

6 / 9

2026-08-22

$5.35

$79,014,681,318

7 / 9

2026-08-23

$5.35

$79,014,681,318

7 / 9

2026-08-24

$5.35

$79,014,681,318

7 / 9

2026-08-25

$5.35

$79,014,681,318

7 / 9

2026-08-26

$5.35

$79,014,681,318

7 / 9

2026-08-27

$5.35

$79,014,681,318

7 / 9

2026-08-28

$5.35

$79,014,681,318

7 / 9

2026-08-29

$5.35

$79,014,681,318

7 / 9

2026-08-30

$5.35

$79,014,681,318

7 / 9

2026-08-31

$5.35

$79,014,681,318

7 / 9

2026-09-01

$5.35

$79,014,681,318

7 / 9

2026-09-02

$5.35

$79,014,681,318

7 / 9

2026-09-03

$5.35

$79,014,681,318

7 / 9

2026-09-04

$5.35

$79,014,681,318

7 / 9

2026-09-05

$5.35

$79,014,681,318

7 / 9

2026-09-06

$5.35

$79,014,681,318

7 / 9

2026-09-07

$5.35

$79,014,681,318

9 / 11

2026-09-08

$5.35

$79,014,681,318

9 / 11

2026-09-09

$5.35

$79,014,681,347

9 / 11

2026-09-10

$5.35

$79,014,681,347

9 / 11

2026-09-11

$5.35

$79,014,681,347

9 / 11

2026-09-12

$5.35

$79,014,681,347

9 / 11

2026-09-13

$5.35

$79,014,681,347

9 / 11

2026-09-14

$5.35

$79,014,681,347

9 / 11

2026-09-15

$5.35

$79,014,681,347

9 / 11

2026-09-16

$5.35

$79,014,681,347

9 / 11

2026-09-17

$5.35

$79,014,681,347

9 / 11

2026-09-18

$5.35

$79,014,681,347

9 / 11

2026-09-19

$5.35

$79,014,681,347

9 / 11

2026-09-20

$5.35

$79,014,681,347

9 / 11

2026-09-21

$5.35

$79,014,681,347

9 / 11

2026-09-22

$5.35

$79,014,681,347

9 / 11

2026-09-23

$5.35

$79,014,681,347

9 / 11

2026-09-24

$5.35

$79,014,681,347

9 / 11

2026-09-25

$5.35

$79,014,681,347

9 / 11

2026-09-26

$5.35

$79,014,681,347

9 / 11

2026-09-27

$5.35

$79,014,681,347

9 / 11

2026-09-28

$5.35

$79,014,681,347

9 / 11

2026-09-29

$5.35

$79,014,681,347

10 / 12

2026-09-30

$5.35

$79,014,681,347

10 / 12

2026-10-01

$5.35

$79,014,681,347

10 / 12

2026-10-02

$5.35

$79,014,681,347

10 / 12

2026-10-03

$5.35

$79,014,681,347

10 / 12

2026-10-04

$5.35

$79,014,681,347

10 / 12

2026-10-05

$5.35

$79,014,681,347

10 / 12

2026-10-06

$5.35

$79,014,681,347

10 / 12

2026-10-07

$5.35

$79,014,681,347

10 / 12

2026-10-08

$5.35

$79,014,681,347

10 / 12

2026-10-09

$5.35

$79,014,681,347

10 / 12

2026-10-10

$5.35

$79,014,681,347

10 / 12

2026-10-11

$5.35

$79,014,681,347

10 / 12

2026-10-12

$5.35

$79,014,681,347

10 / 12

2026-10-13

$5.35

$79,014,681,347

10 / 12

2026-10-14

$5.35

$79,014,681,347

10 / 12

2026-10-15

$5.35

$79,014,681,347

10 / 12

Supermicro (SMCI)

What could strengthen or challenge Supermicro’s outlook?

Living FV™

What performance would support the market price?

Operating margin

QuarterlyIQ assumptions

Operating estimates

What would close the gap?

Revenue and growth

Company initiatives in this report

Operating profitability

Company initiatives in this report

Capital and cash timing

Company initiatives in this report

Performance needed for a target price

What the Thesis Depends On

Incoming Evidence

Expectations trend

Outlook in Brief

What's improving

Still unresolved / key risks

Next proof point

Historical risk context

Supermicro outlook in detail

What kind of bet this is

What's priced into Supermicro

What the fundamentals likely do

What Supermicro hinges on

Bottom line

Analyst view

Price-target changes

Bottom line

Date	Buy*	Hold	Sell*
2026-05-01	5	10	4
2026-06-01	5	11	3
2026-07-01	5	11	3
2026-08-01	5	11	3
2026-09-01	5	11	3
2026-10-01	5	11	3